timothy albertson
timothy albertson
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial
CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ...
Jama 271 (23), 1836-1843, 1994
Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome
JE Gadek, SJ DeMichele, MD Karlstad, ER Pacht, M Donahoe, ...
Critical care medicine 27 (8), 1409-1420, 1999
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US
S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ...
JAMA internal medicine 180 (11), 1436-1447, 2020
The stability of arterial blood gases during transportation of patients using the RespirTech PRO
M Romano, OG Raabe, W Walby, TE Albertson
The American journal of emergency medicine 18 (3), 273-277, 2000
Angiotensin II for the treatment of vasodilatory shock
A Khanna, SW English, XS Wang, K Ham, J Tumlin, H Szerlip, LW Busse, ...
New England Journal of Medicine 377 (5), 419-430, 2017
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
A Khan, C Benthin, B Zeno, TE Albertson, J Boyd, JD Christie, R Hall, ...
Critical care 21, 1-9, 2017
A multicenter study of physicians' knowledge of the pulmonary artery catheter
TJ Iberti, EP Fischer, AB Leibowitz, EA Panacek, JH Silverstein, ...
Jama 264 (22), 2928-2932, 1990
Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19
S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ...
JAMA internal medicine 181 (1), 41-51, 2021
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F (ab′) 2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels
EA Panacek, JC Marshall, TE Albertson, DH Johnson, S Johnson, ...
Critical care medicine 32 (11), 2173-2182, 2004
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
R Hirschberg, J Kopple, P Lipsett, E Benjamin, J Minei, T Albertson, ...
Kidney international 55 (6), 2423-2432, 1999
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial
RD MacArthur, M Miller, T Albertson, E Panacek, D Johnson, L Teoh, ...
Clinical infectious diseases 38 (2), 284-288, 2004
Pressure controlled inverse ratio ventilation in severe adult respiratory failure
RS Tharratt, RP Alle, TE Albertson
Chest 94 (4), 755-762, 1988
The asthma‐COPD overlap syndrome: a common clinical problem in the elderly
AA Zeki, M Schivo, A Chan, TE Albertson, S Louie
Journal of allergy 2011 (1), 861926, 2011
Methamphetamine and the expanding complications of amphetamines.
TE Albertson, RW Derlet, BE Van Hoozen
Western Journal of Medicine 170 (4), 214, 1999
Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States
JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ...
American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021
The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations
S Louie, AA Zeki, M Schivo, AL Chan, KY Yoneda, M Avdalovic, ...
Expert review of clinical pharmacology 6 (2), 197-219, 2013
Tramadol exposures reported to statewide poison control system
KA Marquardt, JA Alsop, TE Albertson
Annals of Pharmacotherapy 39 (6), 1039-1044, 2005
From vital signs to clinical outcomes for patients with sepsis: a machine learning basis for a clinical decision support system
E Gultepe, JP Green, H Nguyen, J Adams, T Albertson, I Tagkopoulos
Journal of the American Medical Informatics Association 21 (2), 315-325, 2014
A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii, MM Juarez, TE Albertson, AL Chan
Journal of thoracic disease 5 (1), 48, 2013
Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome
JG Weg, RA Balk, RS Tharratt, SG Jenkinson, JB Shah, D Zaccardelli, ...
Jama 272 (18), 1433-1438, 1994
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20